Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-039770
Filing Date
2019-07-01
Accepted
2019-07-01 17:01:19
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7343
2 POA DOCUMENT poa.txt EX-24.4_862744 2287
  Complete submission text file 0001209191-19-039770.txt   11050
Mailing Address C/O SAETTLE GENETICS INC 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DOBMEIER ERIC (Reporting) CIK: 0001202785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 19933948

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)